Global Bio Pharma Logistics Market Size/Share Projected to Gain USD 192.52 Billion By 2032

2 minutes read

Global Bio Pharma Logistics Market Size Projected to Gain USD 192.52 Billion By 2032 — A Refrigerated Pharma Logistics Truck

Polaris Market Research, a leading market research firm, has released a comprehensive report projecting the global Bio Pharma Logistics market to surge from USD 96.42 billion in 2022 to USD 192.52 billion by 2032. The market is expected to exhibit a robust Compound Annual Growth Rate (CAGR) of 7.2% from 2023 to 2032. The report, titled “Bio Pharma Logistics Market Share, Size, Trends, Industry Analysis Report,” provides a 360-degree view of the market, encompassing various factors influencing its growth.

Overview of Bio Pharma Logistics in the Pharmaceutical Industry

Bio Pharma Logistics involves the intricate handling, storage, and transportation of diverse pharmaceutical products. Vital to the functioning of biopharma companies, logistics ensures the timely and secure delivery of drugs and equipment, often under critical circumstances. The logistics processes must maintain a controlled environment, crucial for products requiring specific conditions during transportation from manufacturing points to end consumers.

The range of biopharma products includes medicines, healthcare products, surgical instruments, raw materials, and biotechnological materials. These products are transported via roadways, sea, airways, and railways. The ability to securely transport vaccines, medicines, and biologics has made bio pharma logistics an integral part of the global pharmaceutical sector, propelling market growth.

Key Players in Biopharma Logistics

The report identifies key players shaping the bio pharma logistics landscape:

AmerisourceBergen Corporation
CEVA Logistics AG
DHL International GmbH (DHL Life Sciences & Healthcare)
FedEx Corporation (FedEx Express)
Fisher Clinical Services, Inc.
Kuehne + Nagel International AG
Marken, a UPS Company
Panalpina World Transport (Holding) Ltd.
QuickSTAT (Quick International Courier)
SF Express Co., Ltd.
SkyCell AG
UPS (United Parcel Service, Inc.)
VersaCold Logistics Services
World Courier, a part of AmerisourceBergen
Zuellig Pharma Holdings Pte. Ltd.

Market Highlights

Market Value:

2023: USD 103.15 billion
2032: USD 192.52 billion
CAGR: 7.2% (2023-2032)

Prime Determinants of Growth, Trends, and Opportunities:

Technological Advances: The market has expanded with advancements in cold chain technology, including temperature-controlled containers and real-time monitoring systems, minimizing the risk of product degradation during transit.
New Biopharmaceutical Products: Increasing development of biopharmaceutical products, such as gene therapies, monoclonal antibodies, and vaccines, is driving the demand for precise temperature control and specific handling protocols.

Trends and Opportunities:

Globalization of Pharmaceutical Production: With the globalization of pharmaceutical production and distribution, a reliable and efficient logistics network is crucial, especially for specialized products like personalized medicine and cell therapies.
Cold Chain Logistics Segment: Expected to witness the highest growth due to the increased demand for advanced cold chain solutions for temperature-sensitive biopharmaceuticals.
Warehousing Segment: Holds the largest market share, driven by the booming pharmaceutical sector, necessitating dedicated storage units meeting stringent regulatory requirements.

Conclusion

The global Bio Pharma Logistics market is on a trajectory of significant growth, driven by technological advancements, a surge in biopharmaceutical product development, and the increasing globalization of pharmaceutical production. The cold chain logistics segment and warehousing segment are poised for substantial expansion, reflecting the industry’s commitment to ensuring the safety, integrity, and timely delivery of pharmaceuticals worldwide.